Simon Jones

3 weeks ago | opticianonline.net | Simon Jones

If you pay attention to the trade show circuit (and nobody would blame you if you didn’t), then you’ll know that Vision Expo East has relocated from Manhattan’s Javits Centre to the warmer climate of Orlando and the Orange County Convention Centre. But this hasn’t been your average trade show relocation. Yes, it’s still on the east coast of the US, but at more than 1,000 miles away, it looks and feels like a different event.

2 months ago | opticianonline.net | Simon Jones

An analysis of data from more than 100 studies and 17,000 children has questioned the effectiveness of myopia management interventions across medicine, light therapy, ophthalmic lenses and contact lenses. The review, published in the Cochrane Library, sought to assess the comparative efficacy and safety of myopia management interventions and generate a relative ranking. Most studies were conducted in China or other Asian countries (66.3%), and North America (14.4%).

2 months ago | opticianonline.net | Simon Jones

No sooner had regulation around noise-cancelling in-ear headphones with self-testing functionality been relaxed in the UK than fresh doubt was raised by audiologists that their overuse might be contributing to impairment in hearing skills.

2 months ago | opticianonline.net | Simon Jones

I try not to think about getting older, but two visual issues are making that rather difficult. The first, presbyopia, can’t be avoided; it comes for us all. Despite making it well into my 40s without so much as a ‘starter progressive’ or ‘booster’ lens, it’s time to accept, and maybe even embrace presbyopia.

2 months ago | opticianonline.net | Simon Jones

Mainline Instruments will distribute the Envision suite of dry eye treatments in the UK after it signed an agreement with InMode. The Envision platform features non-surgical dry eye treatments that focusdelicate subdermal layers in the periorbital area; including Lumecca-I intense pulsed light; Forma-I thermal bipolar radiofrequency and Morpheus8 fractional skin treatment to stimulate the underlying layers of the dermis.